{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T16:37:30Z","timestamp":1758127050397},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[1996,1,1]],"date-time":"1996-01-01T00:00:00Z","timestamp":820454400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Neural Transmission"],"published-print":{"date-parts":[[1996,1]]},"DOI":"10.1007\/bf01292613","type":"journal-article","created":{"date-parts":[[2005,3,24]],"date-time":"2005-03-24T22:24:50Z","timestamp":1111703090000},"page":"17-30","source":"Crossref","is-referenced-by-count":15,"title":["SDZ GLC 756, a novel octahydrobenzo[g]quinoline derivative exerts opposing effects on dopamine D1 and D2 receptors"],"prefix":"10.1007","volume":"103","author":[{"given":"R.","family":"Markstein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Gull","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"R\ufffddeberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Urwyler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. L.","family":"Jaton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. O.","family":"Kalkman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. K.","family":"Dixon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Hoyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1007\/BF00428200","volume":"85","author":"J Arnt","year":"1985","unstructured":"Arnt J, Hyttel J (1985) Differential involvement of dopamine D1 and D2 receptors in the circling behaviour induced by apomorphine, SKF 38393, pergolide and LY 171555 in 6-hydroxydopamine-lesioned rats. Psychopharmacology 85: 346?352","journal-title":"Psychopharmacology"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0014-2999(86)90588-1","volume":"131","author":"AR Braun","year":"1986","unstructured":"Braun AR, Chase TN (1986) Obligatory D1\/D2 receptor interaction in the generation of dopamine agonist related behaviors. Eur J Pharmacol 131: 301?306","journal-title":"Eur J Pharmacol"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/BF00173535","volume":"346","author":"AT Bruinvels","year":"1992","unstructured":"Bruinvels AT, Lery H, Nozulak J, Palacios JM, Hoyer D (1992) 5-HT1D binding sites in various species: similar pharmacological profile in dog, monkey, calf, guinea-pig and human brain membranes. Naunyn Schmiedebergs Arch Pharmacol 346: 243?248","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1176\/ajp.135.2.164","volume":"135","author":"A Carlsson","year":"1978","unstructured":"Carlsson A (1978) Antipsychotic drugs, neurotransmitters and schizophrenia. Am J Psychiatry 135: 164?173","journal-title":"Am J Psychiatry"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","volume":"22","author":"YC Cheng","year":"1973","unstructured":"Cheng YC, Prusoff WH (1973) Relationship between the inhibition constant Ki and the concentration which caused 50% inhibition (IC50) of an enzymatic reaction. Biochem Pharmacol 22: 3099?3108","journal-title":"Biochem Pharmacol"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/BF01252239","volume":"62","author":"A Closse","year":"1985","unstructured":"Closse A, Frick W, Markstein R, Maurer R, Nordmann R (1985) [3H]205-501, a non-catechol dopaminergic agonist labels selectively and with high affinity for dopamine D2 receptors. J Neural Transm 62: 231?248","journal-title":"J Neural Transm"},{"key":"CR7","first-page":"553","volume":"256","author":"GJ Christ","year":"1991","unstructured":"Christ GJ, Jean-Jaques M (1991) Mutual-effect amplification of contractile response elicited by simultaneous activation of alpha-1 adrenergic and 5-hydroxytryptamine2 receptors in isolated rat aorta. J Pharmacol Exp Ther 256: 553?561","journal-title":"J Pharmacol Exp Ther"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0014-2999(92)90689-2","volume":"213","author":"SA Daly","year":"1992","unstructured":"Daly SA, Waddington JL (1992) Two directions of dopamine D\/D2 receptor interaction in studies of behavioral regulation: a finding generic to four new, selective dopamine D1 receptor antagonists. Eur J Pharmacol 213: 251?258","journal-title":"Eur J Pharmacol"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0197-0186(92)90166-O","volume":"20","author":"MBA Djamgoz","year":"1992","unstructured":"Djamgoz MBA, Wagner HJ (1992) Localization and function of dopamine in the adult vertebrate retina. Neurochem Int 20: 139?191","journal-title":"Neurochem Int"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/BF00501307","volume":"317","author":"G Engel","year":"1981","unstructured":"Engel G, Hoyer D, Berthold R, Wagner H (1981) (\ufffd)[125 Iodo]cyanopindolol, a new ligand for ?-adrenoceptors: Identification and quantification of subclasses of ?-adrenoceptors in guinea pig. Naunyn Schmiedebergs Arch Pharmacol 317: 277?285","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0165-6147(94)90136-8","volume":"15","author":"APDW Ford","year":"1994","unstructured":"Ford APDW, Williams TJ, Blue DR, Clarke DE (1994) ?1-adrenoceptor classification: sharpening ocam's razor. Trends Pharmacol Sci 15: 167?170","journal-title":"Trends Pharmacol Sci"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1037\/h0077500","volume":"92","author":"G Fouriezos","year":"1978","unstructured":"Fouriezos G, Hansson P, Wise RA (1978) Neuroleptic induced attenuation of brain stimulation reward in rats. J Comp Physiol Psychol 92: 661?671","journal-title":"J Comp Physiol Psychol"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/0024-3205(76)90331-3","volume":"18","author":"EK Frandsen","year":"1976","unstructured":"Frandsen EK, Krishna G (1976) A simple ultrasensitive method for the assay of cyclic AMP and cyclic GMP in tissues. Life Sci 18: 529?542","journal-title":"Life Sci"},{"key":"CR14","first-page":"283","volume":"33","author":"RF Furchgott","year":"1972","unstructured":"Furchgott RF (1972) The classification of adrenoceptors (adrenergic receptors). An evaluation from the standpoint of receptor theory. Handbook Exp Pharmacol 33: 283?335","journal-title":"Handbook Exp Pharmacol"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/BF00505800","volume":"313","author":"M G\ufffdthert","year":"1980","unstructured":"G\ufffdthert M, Huth H (1980) Alpha-adrenoceptor-mediated modulation of 5-hydroxytryptamine release from rat brain cortex slices. Naunyn Schmiedebergs Arch Pharmacol 313: 21?26","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"CR16","first-page":"11","volume":"55","author":"O Hornykiewicz","year":"1988","unstructured":"Hornykiewicz O (1988) Neurochemical pathology of Parkinson's disease: basic facts and hypothetical possibilities. Mt Sinai J Med 55: 11?20","journal-title":"Mt Sinai J Med"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0014-2999(85)90658-2","volume":"118","author":"D Hoyer","year":"1985","unstructured":"Hoyer D, Engel G, Kalkman HO (1985) Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes. Radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT, (?)[125I]iodocyanopindolol, [3H]mesulergine and [3H]ketanserin. Eur J Pharmacol 118: 13?25","journal-title":"Eur J Pharmacol"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/0165-6147(89)90159-4","volume":"10","author":"D Hoyer","year":"1989","unstructured":"Hoyer D, Middlemiss DN (1989) Species differences in the pharmacology of terminal 5- HT autoreceptors in mammalian brain. Trends Pharmacol Sci 10: 130?132","journal-title":"Trends Pharmacol Sci"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/0028-3908(84)90079-0","volume":"23","author":"J Hyttel","year":"1984","unstructured":"Hyttel J (1984) Functional evidence for selective D-1 receptor blockade by SCH 23390. Neuropharmacology 23: 1395?1401","journal-title":"Neuropharmacology"},{"key":"CR20","first-page":"505","volume-title":"Psychopharmacology. The third generation of progress","author":"DC Jimerson","year":"1987","unstructured":"Jimerson DC (1987) Role of dopamine mechanisms in the affective disorders. In: Meltzer H (ed) Psychopharmacology. The third generation of progress. Raven Press, New York, pp 505?511"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/277093a0","volume":"277","author":"JW Kebabian","year":"1979","unstructured":"Kebabian JW, Calne DB (1979) Multiple receptors for dopamine. Nature 277: 93?96","journal-title":"Nature"},{"key":"CR22","first-page":"40","volume-title":"The neurobiology of dopaminergic systems","author":"R Markstein","year":"1986","unstructured":"Markstein R (1986) Pharmacological characterisation of central dopamine receptors using functional criteria. In: Winlow W, Markstein R (eds) The neurobiology of dopaminergic systems. Manchester University Press, Manchester, pp 40?52"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/BF01244340","volume":"69","author":"R Markstein","year":"1987","unstructured":"Markstein R, Enz A, Vigouret JM, Jaton A, Closse A, Briner U, Gull P (1987) Biochemical, behavioural, and endocrine effects of CK 204-933, a novel 8-?-ergolene. J Neural Transm 69: 179?199","journal-title":"J Neural Transm"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1210\/endo-94-4-1077","volume":"94","author":"RM McLeod","year":"1974","unstructured":"McLeod RM, Lehmeyer JE (1974) Studies on the mechanism of the dopamine-mediated inhibition of prolactin secretion. Endocrinology 94: 1077?1084","journal-title":"Endocrinology"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1358\/dof.1988.013.10.70082","volume":"13","author":"R Nordmann","year":"1988","unstructured":"Nordmann R, Fl\ufffdckiger EW, Petcher TJ, Brownell J (1988) Endocrine actions of the potent dopamine D2 agonist CV 205-502 and related octahydrobenz[g]quinolines. Drugs of the Future 13: 951?958","journal-title":"Drugs of the Future"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/0166-2236(87)90151-2","volume":"10","author":"MA Rogawski","year":"1987","unstructured":"Rogawski MA (1987) New directions in neurotransmitter action: dopamine provides some important clues. Trends Neurosci 10: 200?205","journal-title":"Trends Neurosci"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1476-5381.1982.tb09283.x","volume":"77","author":"RR Ruffolo","year":"1982","unstructured":"Ruffolo RR, Waddell JE (1982) Receptor interactions of imidazolines: ?-adrenoceptors of rat and rabbit aortae differentiated by relative potencies, affinities and efficacies of imidazoline agonists. Br J Pharmacol 77: 169?176","journal-title":"Br J Pharmacol"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/BF00500087","volume":"332","author":"C R\ufffddeberg","year":"1986","unstructured":"R\ufffddeberg C, Urwyler S, Schulthess C, Herrling PL (1986) Biochemical and pharmacological effects of fluperlapine on noradrenaline and acetylcholine systems in some rodent, bovine and crustacean preparations. Naunyn Schmiedebergs Arch Pharmacol 332: 357?354","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"CR29","first-page":"229","volume":"32","author":"P Seeman","year":"1980","unstructured":"Seeman P (1980) Brain dopamine receptors. Pharmacol Rev 32: 229?313","journal-title":"Pharmacol Rev"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0165-6147(92)90025-2","volume":"13","author":"DR Sibley","year":"1992","unstructured":"Sibley DR, Monsma FJ (1992) Molecular biology of dopamine receptors. Trends Pharmacol Sci 13: 61?69","journal-title":"Trends Pharmacol Sci"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/0165-6147(80)90018-8","volume":"1","author":"K Starke","year":"1980","unstructured":"Starke K (1980) Presynaptic receptors and the control of noradrenaline release. Trends Pharmacol Sci 1: 268?271","journal-title":"Trends Pharmacol Sci"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/BF00512467","volume":"323","author":"K Starke","year":"1983","unstructured":"Starke K, Sp\ufffdth JD, Adelung C (1983) Further functional in vitro comparison of pre- and postsynaptic dopamine receptors in the rabbit caudate nucleus. Naunyn Schmiedebergs Arch Pharmacol 323: 298?306","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/BF00501218","volume":"309","author":"JC Stoof","year":"1979","unstructured":"Stoof JC, Thieme RE, Vrijmoe-de Vries MC, Mulder AH (1979) In vitro acetylcholine release from rat caudate nucleus as a new model for testing drugs with dopamine receptor activity. Naunyn Schmiedebergs Arch Pharmacol 309: 119?124","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/BF00498554","volume":"299","author":"HD Taube","year":"1977","unstructured":"Taube HD, Starke K, Borowski E (1977) Presynaptic receptor systems on the noradrenergic neurones of rat brain. Naunyn Schmiedebergs Arch Pharmacol 299: 123?141","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1111\/j.1471-4159.1986.tb00618.x","volume":"46","author":"S Urwyler","year":"1986","unstructured":"Urwyler S, Markstein R (1986) Identification of dopamine D3 and D4 binding sites with [3H]2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronapthalene, as high agonist affinity states of D1 and D2 dopamine receptors, respectively. J Neurochem 46: 1058?1067","journal-title":"J Neurochem"},{"issue":"Suppl 1","key":"CR36","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1159\/000136817","volume":"16","author":"JM Vigouret","year":"1978","unstructured":"Vigouret JM, Buerki HR, Jaton AL, Zueger PE, Loew DM (1978) Neurochemical and neuropharmacological investigations with four ergot derivatives: bromocriptine, dihydroergotoxine, CF 25-397 and CM 29-712. Pharmacology 16 [Suppl 1]: 156?173","journal-title":"Pharmacology"},{"key":"CR37","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/BF00175783","volume":"337","author":"C Waeber","year":"1988","unstructured":"Waeber C, Schoeffter P, Palacios JM, Hoyer D (1988) Molecular pharmacology of 5-HT1D recognition sites: radioligand binding studies in human, pig and calf brain mem-branes. Naunyn Schmiedebergs Arch Pharmacol 337: 595?601","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"CR38","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1152\/physrev.1978.58.4.905","volume":"58","author":"RI Weiner","year":"1978","unstructured":"Weiner RI, Ganong WF (1978) Role of brain monoamines and histamine in regulation of anterior pituitary secretion. Physiol Rev 58: 905?976","journal-title":"Physiol Rev"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01292613.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01292613\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01292613","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,2]],"date-time":"2019-05-02T11:15:21Z","timestamp":1556795721000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01292613"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,1]]},"references-count":38,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[1996,1]]}},"alternative-id":["BF01292613"],"URL":"https:\/\/doi.org\/10.1007\/bf01292613","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,1]]}}}